Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Little Green Pharma Ltd. ( (AU:LGP) ).
Little Green Pharma has applied to the Australian Securities Exchange for quotation of 210,000 new ordinary fully paid shares. The new securities, issued on 26 February 2026, reflect the exercise or conversion of existing options or other convertible instruments and will expand the company’s quoted share capital, modestly increasing liquidity for investors.
The application confirms compliance with ASX Listing Rule requirements for new securities quotation. While the issuance is relatively small, it indicates ongoing utilisation of equity-based instruments within the company’s capital management strategy and marginally broadens the tradable float available to shareholders.
The most recent analyst rating on (AU:LGP) stock is a Buy with a A$0.18 price target. To see the full list of analyst forecasts on Little Green Pharma Ltd. stock, see the AU:LGP Stock Forecast page.
More about Little Green Pharma Ltd.
Little Green Pharma Ltd is an Australian-listed company in the pharmaceuticals sector, trading under the ASX code LGP. The company issues ordinary fully paid shares and is subject to the ASX Listing Rules in relation to the quotation and trading of its securities.
Average Trading Volume: 218,318
Technical Sentiment Signal: Sell
Current Market Cap: A$35.15M
For a thorough assessment of LGP stock, go to TipRanks’ Stock Analysis page.